786 results on '"Zivanovic, Oliver"'
Search Results
102. Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes
103. Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center
104. Herniation formation in women undergoing robotically assisted laparoscopy or laparotomy for endometrial cancer
105. Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
106. Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study
107. Prognostic significance of supraclavicular lymphadenopathy in patients with high-grade serous ovarian cancer
108. Understanding Inherited Risk in Unselected Newly Diagnosed Patients With Endometrial Cancer
109. Small Bowel and Large Bowel Resection and Anastomosis
110. Contributors
111. Chemotherapy response in low‐grade serous ovarian carcinoma at a comprehensive cancer center: Readdressing the roles of platinum and cytotoxic therapies
112. The necessity to adhere to evidence-based indications for hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with ovarian cancer
113. Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancer
114. O015/#502 Molecular stratification of ovarian clear cell carcinoma predicts clinical outcomes
115. FF001/#573 Near-infrared angiography for assessment of rectosigmoid anastomoses in gynecologic surgery
116. EP388/#630 Creating a multidisciplinary protocol for the administration of hyperthermic intraperitoneal chemotherapy with cisplatin: a single-institution experience
117. EP214/#508 Outcomes and long-term follow-up by treatment type for patients with advanced-stage ovarian cancer managed at a tertiary cancer center
118. 23/#722 Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies
119. O036/#221 Intrathoracic surgery as part of primary cytoreduction for advanced ovarian cancer – going to the next level: a memorial sloan kettering team ovary study
120. Is there a role for hyperthermic intraperitoneal chemotherapy in ovarian cancer?
121. Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation
122. Small cell neuroendocrine carcinoma of the cervix: Analysis of prognostic factors and patterns of metastasis
123. Prognostic significance of tumor-associated macrophages in endometrial adenocarcinoma
124. A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer
125. Chapter 4 - Ovarian clear cell carcinoma
126. Postoperative outcomes among patients undergoing thoracostomy tube placement at time of diaphragm peritonectomy or resection during primary cytoreductive surgery for ovarian cancer
127. Contributors
128. Long-Term Oncologic Outcomes of Uterine-Preserving Surgery in Young Women With Stage Ib1 Cervical Cancer
129. Risk of Ovarian Malignancy in Patients Undergoing Surgery for an Adnexal Mass at a High-Volume Cancer Center [36A]
130. Ovarian Cancer Treatment — Are We Getting Warmer?
131. Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family
132. Impact of Obesity on Sentinel Lymph Node Mapping in Patients with Newly Diagnosed Uterine Cancer Undergoing Robotic Surgery
133. Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer
134. Is It Time to Centralize Ovarian Cancer Care in the United States?
135. Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping
136. High-Sensitivity Mutation Analysis of Cell-Free DNA for Disease Monitoring in Endometrial Cancer
137. Postoperative morbidity after secondary cytoreductive surgery for platinum-sensitive recurrent ovarian cancer: An exploratory analysis of a randomized phase II study evaluating hyperthermic intraperitoneal chemotherapy (530)
138. Sentinel lymph node mapping in patients with endometrial hyperplasia: A practice to preserve or abandon? (117)
139. Ten-year conditional probability of survival for patients with ovarian cancer: A new metric for the new millennium (480)
140. The impact of bowel preparation on surgical site infection rates in gynecologic oncology surgery, post-hoc analysis from a randomized controlled trial (550)
141. A preoperative tool for estimating the risk of blood transfusion over an ovarian cancer debulking surgery (113)
142. Oncologic outcomes of secondary cytoreductive surgery in the era of poly (ADP-ribose) polymerase inhibitors maintenance (549)
143. Predicting outcomes in female germ cell patients using a modified International Germ Cell Cancer Collaborative Group classification system to guide management (100)
144. Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis
145. Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer
146. Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer
147. An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT)
148. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status
149. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma
150. The effects of neoadjuvant chemotherapy and interval debulking surgery on body composition in patients with ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.